Skip to main content

Table 1 Clinical characteristics of the patients with tuberculous pleurisy

From: In-hospital outcome of patients with culture-confirmed tuberculous pleurisy: clinical impact of pulmonary involvement

 

Isolated pleurisy group (N = 51)

Pleuro-pulmonary group (N = 154)

p value

Age (years)

52.6 [27.7]

70.4 [16.5]

< 0.001

Age ≥ 65 years

23 (43%)

114 (74%)

< 0.001

Male gender

35 (69%)

114 (74%)

0.453

Underlying co-morbid condition*

14 (27%)

72 (47%)

0.015

   Diabetes mellitus

4 (8%)

27 (18%)

0.118

   Malignancy

7 (14%)

22 (14%)

0.921

   Renal failure

3 (6%)

16 (10%)

0.575

   Cirrhosis of liver

2 (4%)

7 (5%)

1.000

   Autoimmune diseases

0

7 (5%)

0.198

   Acquired immunodeficiency syndrome#

1 (2%)

5 (3%)

1.000

Symptoms

   

   Duration, days

17.8 [31.0]

17.3 [27.4]

0.923

   Cough

2 (4%)

19 (12%)

0.112

   Fever

26 (51%)

43 (28%)

0.002

   Dyspnea

13 (25%)

51 (33%)

0.360

   Chest pain

6 (12%)

3 (2%)

0.007

   Others†

4 (8%)

38 (25%)

0.010

  1. Data are no. (%) or mean [SD]
  2. * Three and twelve in the isolated pleurisy group and pleuro-pulmonary group, respectively, had two underlying co-morbid conditions.
  3. † Other symptoms included gastrointestinal symptoms, consciousness change and other non-specific symptoms.
  4. # 63 patients received human immunodeficiency tests.